Paper · 6961402
Circular dichroism spectroscopy of heparin-antithrombin interactions.
Stone AL and 3 others. Proc Natl Acad Sci U S A, 1982. Cited by 74 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Circular dichroism spectroscopy of heparin-antithrombin interactions. Papers, record 6961402. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6961402
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antithrombins | Major topic |
| Heparin | Major topic |
| Binding Sites | |
| Carbohydrate Sequence | |
| Circular Dichroism | |
| Molecular Weight | |
| Oligosaccharides | |
| Protein Conformation | |
| Spectrophotometry, Ultraviolet | |
| Structure-Activity Relationship |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| GM26625 | NIGMS NIH HHS | United States | P01GM026625 | PubMed and NIH | NIH RePORTER |
| HL-28625 | NHLBI NIH HHS | United States | R01HL028625 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,817,721 | Fine structure in the near-ultraviolet circular dichroism and absorption spectra of tryptophan derivatives and chymotrypsinogen A at 77 degrees K. | Biochemistry | 1969 | https://conductscience.org/library/papers/5817721 | PubMed |
| 2 | 4,738,234 | The purification and mechanism of action of human antithrombin-heparin cofactor. | J Biol Chem | 1973 | https://conductscience.org/library/papers/4738234 | PubMed |
| 3 | 4,591,332 | Aromatic contributions to circular dichroism spectra of proteins. | CRC Crit Rev Biochem | 1974 | https://conductscience.org/library/papers/4591332 | PubMed |
| 4 | 1,267,803 | The separation of active and inactive forms of heparin. | Biochem Biophys Res Commun | 1976 | https://conductscience.org/library/papers/1267803 | PubMed |
| 5 | 1,278,445 | Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin. | FEBS Lett | 1976 | https://conductscience.org/library/papers/1278445 | PubMed |
| 6 | 836,327 | Evidence for a heparin-induced conformational change on antithrombin III. | Biochem Biophys Res Commun | 1977 | https://conductscience.org/library/papers/836327 | PubMed |
| 7 | 410,640 | The size and shape of human and bovine antithrombin III. | Eur J Biochem | 1977 | https://conductscience.org/library/papers/410640 | PubMed |
| 8 | 277,908 | Structure-function relationships of heparin species. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/277908 | PubMed |
| 9 | 687,588 | Binding of low-affinity and high-affinity heparin to antithrombin. Ultraviolet difference spectroscopy and circular dichroism studies. | Biochemistry | 1978 | https://conductscience.org/library/papers/687588 | PubMed |
| 10 | 429,327 | Fractionation of low molecular weight heparin species and their interaction with antithrombin. | J Biol Chem | 1979 | https://conductscience.org/library/papers/429327 | PubMed |
1 to 10 of 20
See all 20 referencesCited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24,068,708 | The allosteric mechanism of activation of antithrombin as an inhibitor of factor IXa and factor Xa: heparin-independent full activation through mutations adjacent to helix D. | J Biol Chem | 2013 | https://conductscience.org/library/papers/24068708 | PubMed |
| 20,524,207 | Multiple mechanisms for exogenous heparin modulation of vascular endothelial growth factor activity. | J Cell Biochem | 2010 | https://conductscience.org/library/papers/20524207 | PubMed |
| 6,721,831 | Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. | Biochem J | 1984 | https://conductscience.org/library/papers/6721831 | PubMed |
| 6,330,171 | Natural anticoagulant mechanisms. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6330171 | PubMed |
| 3,800,942 | The relative molecular mass dependence of the anti-factor Xa properties of heparin. | Biochem J | 1986 | https://conductscience.org/library/papers/3800942 | PubMed |
| 3,473,488 | Expression of functionally active human antithrombin III. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3473488 | PubMed |
| 3,111,566 | The haemostatic function of the vascular endothelial cell. | Blut | 1987 | https://conductscience.org/library/papers/3111566 | PubMed |
| 2,948,492 | Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates. | Biochem J | 1986 | https://conductscience.org/library/papers/2948492 | PubMed |
| 2,529,852 | Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa. | Biochem J | 1989 | https://conductscience.org/library/papers/2529852 | PubMed |
| 2,263,629 | Cell mutants defective in synthesizing a heparan sulfate proteoglycan with regions of defined monosaccharide sequence. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2263629 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F10 | 2,159 | PubTator's text mining | https://conductscience.org/library/genes/2159 | NCBI Gene |
| F2 | 2,147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
| SERPINC1 | 462 | PubTator's text mining | https://conductscience.org/library/genes/462 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6961402
GET https://conductscience.org/api/papers/v1/6961402/authors